Omnia Family Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Omnia Family Wealth's BMY Position: Q2 2026 in Review
Omnia Family Wealth increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $24.6K and bringing the position to 3,907 shares worth $225K. The position accounts for 0.06% of the portfolio, ranked #90.
Omnia Family Wealth first reported a position in BMY in Q4 2016 and has held it in 12 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Omnia Family Wealth held 3,907 shares of Bristol-Myers Squibb worth $225K as of Q2 2026.
- Omnia Family Wealth bought 428 Bristol-Myers Squibb shares in Q2 2026, an estimated $24.6K.
- Bristol-Myers Squibb made up 0.06% of Omnia Family Wealth's portfolio in Q2 2026, its #90 holding.
- Omnia Family Wealth first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 12 quarters since.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Omnia Family Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.